You are here

Iodine therapy

Document

Fibrosing interstitial lung disease - Iodine therapy Factor

Last reviewed for CCPS 16 December 2009.

Preliminary questions [40666]

40685 there is some evidence that iodine-131 therapy may be a factor in the development or worsening of the condition under consideration.

40978 the veteran has received iodine-131 as therapy at some time.

40979 the veteran received iodine-131 as therapy for widespread pulmonary metastases from a malignant neoplasm of the thyroid.

40980the veteran received iodine-131 as therapy for treatment of an illness or injury which is identifiable.

40983the veteran has established the causal connection between iodine-131 as therapy and VEA service for fibrosing interstitial lung disease.

40981

for treatment of the identified illness or injury, the veteran received iodine-131 as therapy before the clinical onset of fibrosing interstitial lung disease.

40984the veteran has established the causal connection between iodine-131 as therapy and VEA service for the clinical onset of fibrosing interstitial lung disease.

40986the veteran has established the causal connection between iodine-131 as therapy and operational service for the clinical onset of fibrosing interstitial lung disease.

or

40987the veteran has established the causal connection between iodine-131 as therapy and eligible service for the clinical onset of fibrosing interstitial lung disease.

or

7334

the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335

the condition under consideration permanently worsened.

40982

for treatment of the identified illness or injury, the veteran received iodine-131 as therapy before the clinical worsening of fibrosing interstitial lung disease.

40985the veteran has established the causal connection between iodine-131 as therapy and VEA service for the clinical worsening of fibrosing interstitial lung disease.

40988the veteran has established the causal connection between iodine-131 as therapy and operational service for the clinical worsening of fibrosing interstitial lung disease.

or

40989the veteran has established the causal connection between iodine-131 as therapy and eligible service for the clinical worsening of fibrosing interstitial lung disease.

Clinical onset and operational service [40986]

40990the identified illness or injury, for which the veteran received iodine-131 as therapy, is causally related to operational service.

Clinical onset and eligible service [40987]

40991the identified illness or injury, for which the veteran received iodine-131 as therapy, is causally related to eligible service.

Clinical worsening and operational service [40988]

40990the identified illness or injury, for which the veteran received iodine-131 as therapy, is causally related to operational service.

40992

the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the veteran received iodine-131 as therapy, is causally related.

Clinical worsening and eligible service [40989]

40991the identified illness or injury, for which the veteran received iodine-131 as therapy, is causally related to eligible service.

40993

the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, for which the veteran received iodine-131 as therapy, is causally related.